about
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber,...
Read More
0.66
0.02
(3.12%)
224.2K
XNAS Volume
High volume today
XNAS 20 Mar, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Cytosorbents Corp is on 31 Mar 2026 for the purpose of CytoSorbents Corp Fourth Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Bearish
Cytosorbents Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..